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Background: Alveolar soft part sarcoma (ASPS) is a rare mesenchymal malignancy. ASPS usually occurs most
commonly in the deep soft tissues of the thigh and buttock or the head and neck regions.
ASPS that originate from the uterine corpus are even more rare, with only 10 previous cases reported in the English
literature.
Case presentation: In our case, the alveolar features were completely lost and the tumour shows a solid, non-
alveolar pattern and the nuclei have marked variation in nuclear size, and multinucleation. The correct pathological
diagnosis has been made by immuno- histochemical and ultrastructural features, which rvealed overexpression of
TFE3 and peculiar cytoplasmic crystalline inclusions.
In this paper, an additional case of primary ASPS of uterine corpus is reported with immunohistochemical, ultrastructural
study and review of literature in the effort to delineate its clinical and pathological features. In this unusual site, the
diagnosis can be problematic because ASPS can mimic other primary or metastatic uterine neoplasms.
Conclusions: Thus, in this unusual presentation an essential diagnostic marker is the nuclear over-expression of TFE3 as
well as ultrastructural study, which reveals the presence of peculiar cytoplasmic crystalline inclusions.
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Alveolar soft part sarcoma (ASPS) is a rare mesen-
chymal malignancy with distinctive histologic and ultra-
structural appearance. ASPS was first described in 1952
by Christopherson et al. as a neoplasm with of uncertain
histogenesis whose cells were arranged in a pattern mim-
icking the small air sacks (alveoli) of the lung [1].
In fact, this neoplasm usually shows uniform, organoid
nests of polygonal cells, separated by fibrovascular septa
and delicate capillary-sized vascular channels. A promin-
ent cellular dyscohesion within the nests results in a dis-
tinctive pseudo-alveolar pattern. Sometimes, the alveolar
features can be completely lost and the tumour may* Correspondence: giovanna.giordano@unipr.it
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nuclei are round-to-polygonal and vesicular, with prom-
inent nucleoli, but cells with marked variation in nuclear
size, nuclear-cytoplasmatic inclusions, and multinucleation
have been reported [3–5]. The cytoplasms are abundant
granular and may contain periodic acid-Schiff-(PAS) posi-
tive, diastase (D)-resistant crystalline structures, rhomboid
or rod-like in shape [6]. The first ultrastructural analysis of
ASPS, made by Shipkey et al. in 1964 [6] and following
studies confirmed the presence of distinctive cytoplasmic
crystals which typically were intermingled with dense
granules [7–9]. More recently, Ladanyi et al., by a com-
bined ultrastructural and immunohistochemistry study,
have demonstrated that these crystals consist of aggregates
of the monocarboxylate transporter protein MCT1 and its
cellular chaperone CD147 [10].cle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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Fig. 1 On cut sections, the tumour was well circumscribed, soft, with
irregular border and showed areas which varied from yellow, brownish
and grey, with a central haemorrhagic area
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characterized by specific chromosomal translocation
der(17)t(X;17) (p11;q25) that fuses the transcription factor
3 (TFE3) gene at Xp11 to the ASPL gene at 17q25, produ-
cing an ASPL–TFE3 fusion protein [11]. This results in
the aberrant and strong nuclear expression of TFE3 which
is seen almost exclusively in tumours harbouring the
TFE3 gene fusions, such as ASPSs and rare paediatric
renal carcinomas [12].
ASPS usually affects adolescents and young adults in
the second and third decades with slight female pre-
dominance [3]. In adults, this malignancy occurs most
commonly in the deep soft tissues of the thigh or
buttock, while in children and infants, the head and
neck regions are often involved [3]. However, many
reports have demonstrated that ASPS can be observed
in unusual sites such as the mediastinum, stomach,
breast, bone, and urinary bladder [13–19].
This neoplasm has been reported also in the female
genital tract [20–26]. As far as we are aware, only 10 cases
of ASPS of uterine corpus have been previously reported
[4, 5, 27–32]. In these unusual sites, the diagnosis can be
problematic because ASPS can mimic other primary or
metastatic neoplasms.
In this paper, an additional case of primary ASPS of
uterine corpus is reported with immunohistochemical,
ultrastructural study and review of literature in the effort
to delineate its clinical and pathological features.
Case presentation
A 66-year-old female was hospitalized for atypical vaginal
bleeding and anaemia. On gynecologic examination, the
uterus was enlarged and the cervix was prolapsed. Trans-
vaginal ultrasound identified a well-circumscribed, intra-
mural nodule measuring 5 cm in diameter, located in the
uterine corpus. The patient underwent total abdominal
hysterectomy and bilateral salpingo-oophorectomy. Intra-
operatively, no ascites or adhesions were seen surrounding
the uterus, ovaries, and salpinges. No enlarged pelvic
lymph nodes were noted neither peritoneal lesions were
found.
Gross pathologic examination revealed thickening of the
cervical mucosa and an intramural, sharply circumscribed,
round, firm, grey-white nodule with trabeculated cut
surface located in the endocervix. The uterine corpus was
enlarged and deformed because of an intramural nodule,
measuring 5 cm in diameter. On cut section, this lesion
was well circumscribed, soft, with irregular border, colour
varying from yellow, brownish and grey and a large haem-
orrhagic zone centrally located (Fig. 1). The ovaries and
salpinges were macroscopically unremarkable.
Histologically, the cervix showed atrophic epithelium
and an intramural leiomyoma. The nodule of the uterine
corpus was characterized by neoplastic cells arrangedin an organoid pattern (Fig. 2a), with nests surrounded by
a delicate fibrovascular septa highlighted by PASD and
anti-CD34 stains. Extensive degenerative changes, such
as hyalinization, haemorrhage and hemosiderin deposits
were observed (Fig. 2b). Most cells had abundant eosino-
philic granular cytoplasm, distinct border and vesicular
nuclei with prominent nucleolus (Fig. 2a). Other cells
were large, with clear vacuolated cytoplasms (Fig. 2c). In
some areas, the organoid pattern was lost and the tumour
showed solid growth; in these areas, the cells were more
spindled and showed nuclear pleomorphism, hyperchro-
masia and pseudo-inclusions and multinucleation (Fig. 2d).
Necrosis and mitoses were absent.
On immunohistochemical analysis, the neoplasm showed
focal immunoreactivity to muscle-specific actin, caldesmon
and caldesmin. Ki 67 index was very low (Fig. 3a). Strong
nuclear positivity to TFE3 was observed in all neoplastic
cells (Fig. 3b). Immunostains for CD 34, CD10, micro-
phthalmia transcription factor (MITF), myoglobin, S-100
protein, HMB-45, neuron-specific enolase, synaptophysin,
chromogranin, cytokeratin, epithelial membrane antigen
(EMA), cyclin D1 and alpha-inhibin were negative. Electron
microscopy (EM) examination revealed cytoplasmic crystal
inclusions showing periodic pattern of about 10 nm in
channels resembling dilated sacs of endoplasmic reticulum
(Fig. 4).
Because of immunohistochemical and ultrastructural
features, such as focal immunoreactivity to muscle-
specific markers (actin, desmin, caldesmin), negativity to
other makers, strong and diffuse nuclear positivity to
TFE3 and the presence of cytoplasmic crystal inclusions,
Fig. 2 Histologically, the tumour showed nests of neoplastic cells with abundant eosinophilic granular cytoplasm, distinct borders and vesicular
nuclei with prominent nucleoli (a haematoxylin and eosin stain ×400). Extensive degenerative changes, such as hyalinization with haemorrhagic
and hemosiderin deposits, were observed (b haematoxylin and eosin stain ×200). Other cells were large with clear vacuolated cytoplasms (c haematoxylin
and eosin stain ×400). In some areas, the organoid pattern was lost and the tumour showed solid growth, made spindle cells with nuclear, pleomorphism,
hyperchromasia, pseudo-inclusions and multinucleations (d haematoxylin and eosin stain ×200)
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soft part sarcoma of uterine corpus. No images suggestive
of other primary or metastatic lesions were observed on
abdominal ultrasound, chest X-ray, total computed tom-
ography or bone scan.
Seven months after surgery, the patient was free of
disease. In fact, when she was readmitted for further
examination, no abnormalities were found in both phys-
ical examination and imaging studies.
Discussion
ASPS is a rare malignant neoplasm, accounting for
0.5–1 % of all soft part sarcomas [33]. ASPS that
originate from the uterine corpus is even more rare,
with only 10 previous cases reported in the English
literature [4, 5, 27–32]. The main clinical andmorphological features of 11 cases (including our present
case) are summarized in Tables 1 and 2.
The age at diagnosis ranged from 14 to 66 years (me-
dian, 43 years). Abnormal uterine bleeding was present in
all patients. The size of the neoplasm varied from 0.4 to
7 cm (median, 3 cm) in diameter. In the majority of cases,
the neoplasm was an intramural nodule. The diagnosis of
ASPS in all cases was supported by histologic and EM
examination, which revealed an alveolar pattern and the
presence of cytoplasmic crystalline inclusions (Table 2).
Usually, the tumour nuclei were round-to-polygonal
and vesicular, with prominent nucleoli, but cells with
marked variation in nuclear size, nuclear cytoplasmatic
inclusions and multinucleation, with very few mitoses
have been observed in our case and in other ASPSs in
the uterine corpus [4, 5] and extragenital sites [3].
Fig. 3 Ki 67 index was very low (a ×200). Strong nuclear positivity to TFE3 was observed in all cells (b ×200)
Giordano et al. World Journal of Surgical Oncology  (2016) 14:24 Page 4 of 8In our case, the alveolar features were completely lost
and the tumour show a solid, non-alveolar pattern and
the nuclei have marked variation in nuclear size,
nuclear-cytoplasmatic inclusions and multinucleation. The
correct pathological diagnosis has been made byFig. 4 In an ultrastructural study, neoplastic cells had cytoplasmic crystallinimmunohistochemical and ultrastructural features, which
revealed focal immunoreactivity to muscle-specific markers
(actin, desmin, caldesmon), negativity to other makers,
strong and diffuse nuclear positivity to TFE3 and the pres-
ence of cytoplasmic crystal inclusions.e inclusions (arrows) showing unidirectional periodicity
Table 1 R1: clinical features of ASPS of the uterus corpus
Authors and years Age Clinical symptoms Therapy Follow-up
Gray et al. (1986) [27] 43 Metromenorrhagia Total hysterectomy NED 9 Mo
Nolan et al. (1990) [28] 14 Menorrhagia and expulsion of a necrotic mass per vagina HBSO NED 80 Mo
Guillou et al. (1991) [4] 40 Abdominal pelvic pain, intermenstrual bleeding Total hysterectomy NED 48 Mo
Burch et al. (1994) [29] 47 Intermenstrual bleeding HBSO NED12 Mo
37 Hypermenorrhea Total hysterectomy NED 66 Mo
Nielsen et al. (1995) [30] 30 Menometrorrhagia Total hysterectomy NED 66 Mo
Radig et al. (1998) [31] 50 Abnormal uterine bleeding HBSO NED 84 Mo
36 Intermenstrual spotting, dysmenorrhoea Hysterectomy NED 8 Mo
Kasashima et al. (2007) [5] 50 Abnormal uterine bleeding HBSO, lymph NED 38 Mo
Zhang et al. (2012) [32] 57 Abnormal uterine bleeding HBSO, lymph chem NED 1 Mo
Present case 66 Abnormal uterine bleeding HBSO NED 7 Mo
ASPS alveolar soft part sarcoma, HBSO hysterectomy with bilateral salpingo-oophorectomy, NED not evidence of disease, Mo months
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alveolar soft part sarcoma because no images suggestive
of other primary or metastatic lesions were observed on
abdominal ultrasound, chest X-ray, total computed tom-
ography or bone scan.
On the contrary, the review of literature revealed an
immunohistochemical profile not very consistent with
variable staining using other markers such as vimentin,
desmin, myoglobin, muscle-specific actin, S-100 protein,
HMB-45, neuron-specific enolase, synaptophysin, chro-
mogranin, cytokeratin, EMA and NK1-C3 (melanoma-
specific antibody) (Table 2). Thus, in our case, nuclear
over-expression of TFE3 can be considered as an essen-
tial diagnostic marker for a correct pathological diagno-
sis. It has been demonstrated that aberrant and strong
nuclear expression of TFE3 is seen exclusively in tu-
mours which contain the TFE3 gene fusions [11], such
as ASPS and rare paediatric renal carcinomas [12]. TFE3
immunoreactivity was first tested in the female genital
tract in a case of ASPS located in the uterine cervix by
Roma et al. in 2005 [26]. TFE3 immunoreactivity in
cases of uterine corpus of ASPSs was evaluated only in
our case and in the examples reported by Kasashima
et al. and by Zhang L et al. [5, 32] (Table 2). The pres-
ence of crystalline inclusions on electron microscopy
further supports the diagnosis of uterine ASPS.
ASPS of the uterine corpus enters in the differential
diagnosis with other neoplasms presenting an admixture
of spindle-to-epithelioid cells with eosinophilic-to-clear
cytoplasm such as epithelioid smooth muscle tumours,
epithelioid endometrial stromal tumours, perivascular
epithelioid cell tumours (PECOMAs), uterine rhabdoid
tumours, carcinomas, melanoma and malignant para-
ganglioma. These tumours characteristically do not show
expression of TFE3 on immunohistochemical analysis
and have other peculiar morphologic and immunohisto-
chemical features.Epithelioid smooth muscle tumours are composed by
mixtures of epithelioid, clear cell. A transition to typical
smooth muscle cells in most instances confirms the
smooth muscle nature of these tumours [34] and are
diffuse immunoreactive for actin and desmin.
Endometrial stromal tumours with a prominent com-
ponent of epithelioid cells and abundant eosinophilic
cytoplasm usually show areas with fusiform cells, charac-
teristic arterioles and strong diffuse cytoplasmic immu-
noreactivity for vimentin and for CD10 [35].
PECOMAs can arise in the uterus and are characterized
by varying amounts of spindle and epithelioid cells with
clear to eosinophilic cytoplasm, with immunoreactivity for
melanocytic markers, most frequently HMB-45 [36].
Malignant rhabdoid tumour is a highly aggressive
tumour in adults and rapidly fatal and was first reported
to have been found in the uterus in 1989 [37]. Histologi-
cally, this rare neoplasm shows solid sheets of large cells
with deep eosinophilic cytoplasm, eosinophilic hyaline
cytoplasmic inclusions, eccentric vesicular nuclei and
prominent nucleoli. On immunohistochemical analysis,
neoplastic cells reveal cytoplasmic staining for vimentin
[38] and keratins [38, 39].
Melanoma and carcinoma can be differentiated from
ASPS because of greater cytologic atypia, pleomorphism,
higher mitotic activity and immunoreactivity, respect-
ively, for epithelial makers and for melanoma-specific
antibodies.
Malignant paraganglioma is characterized by polygonal
to oval cells arranged in distinctive cell balls, called
Zellballen, and shows more pronounced cell pleomorph-
ism and immunoreactivity for neuroendocrine markers,
such as neuron-specific enolase, protein gene product
9.5, synaptophysin and the presence of neurosecretory
granules on EM examination [40].
In extragenital sites, ASPS presents an indolent clinical
course with unpredictable prognosis. Metastases to the
Table 2 Pathological findings of ASPS of the uterus corpus
Authors
and years





Large cell, arranged in organoid appearance separated by
delicate fibrovascular stroma
ND Membrane bound crystalline





Mass of 7 cm, bulging into endometrial
cavity
Large cells with granular and vacuolated cytoplasms, organoid





3 × 2.5 × 2.5 cm well-circumscribed
intramyometrial nodule
Uncapsulated lesion pushing border delineated by
endometrium, large cells with organoid arrangement, separated
by fibrovascular septae, granular cytoplasms with crystals.
Areas with nuclear pleomorphism
POS Vim, focal POS HMB45, NKI/C3,








1-cm intramural nodule Large cell, arranged in organoid appearance separated by
delicate fibrovascular stroma crystals on PAS D
ND ND
3.5-cm submucosal nodule Large cell, arranged in organoid appearance separated by
delicate fibrovascular stroma, crystals on PAS D
ND ND




Pseudoalveolar and trabecular pattern, polygonal and round
cells vesicular nuclei, with nucleoli, crystals on PAS D
NEG for S100, Ck, EMA, POS caldes Intracytoplasmic crystalline
inclusions
4.5-cm well-circumscribed, intramural nodule Pseudoalveolar pattern, granular ND Intracytoplasmic crystalline
inclusions absent
Kasashima S
et al. (2007) [5]
1.9 × 1.9 × 1.0 cm greyish, endometrial
exophytic nodule
Large cells with organoid arrangement, separated by
fibrovascular septae, granular cytoplasms with crystals
Nuclear POS: TFE3, PGR, ER, CD10 ND
Vesicular nuclei and pleomorphic nuclei and multinucleated
cells. Mitoses very rare. No M Lym
NEG: Vim, caldes, Sma, Myo, HMB45, S100,
EMA, Chrom, Syn, Myoge, Myogl
Zhang et al.
(2012) [32]
2.4 × 2.0 × 1.8 cm yellow-whitish exophytic
tumour, sub-endometrium of the lower
uterine segment
Large cells with organoid arrangement, separated by delicate
fibrovascular septae, granular cytoplasms with crystalsM lymph
NEG: Ae1/AE3, EMA, Sma, Des, S-100,
CD10, Synapt, Chrom
ND
Ki67: 5 % diffuse POS Nuclear TFE3
Present case 5-cm intramural nodule, well-circumscribed,
with irregular border , soft yellow, brownish
and grey, with a large haemorrhagic zone
centrally located
Solid “non-organoid” pattern, abundant eosinophilic granular
cytoplasm, with distinct border, and vesicular nuclei and
prominent nucleolus
Focal POS to Sma, desm, Caldes and
diffuse and strong nuclear POS to TFE3
NEG: Ae1/AE3, EMA, Sma, Des, S-100,
CD10, NSE, Synapt, Chrom, inh, MiTF
Intracytoplasmic crystalline
inclusions
Areas with spindle elements with nuclear, pleomorphism,
hyperchromasia, nuclear cytoplasmic pseudo-inclusions
and multinucleations
Diffuse POS nuclear TFE3
ASPS alveolar soft part sarcoma, Caldes caldesmin, Chrom chromogranin, CK cytokeratin, EMA epithelial membrane antigen, ER oestrogen receptor, caldes caldesmon, Immu immunohistochemistry, inh alpha-inhibin, Lym lymph
node, lw low weight, MLymph lymphonodal metastasis, MITF microphthalmia transcription factor, Mo months, Myoge myogenin, Myogl myoglobin, ND not done, NSE neuron-specific enolase, PASDR periodic acid-Schiff diastase
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Lesions with size less than 5 cm in diameter seem to be
correlated with a more favourable outcome [43]. ASPS in
the uterine corpus has a better prognosis than ASPSs in
the soft tissues and other cases located in the vagina. All
patients with ASPS located in the uterine corpus were alive
and well at the time of the last follow-up (Table 1). In con-
trast, one of six patients with vaginal ASPS died as a result
of the tumour. Initially, this patient had a recurrence
4 months after local excision and external radiation ther-
apy and then died of the disease with pulmonary metasta-
ses 25 months later [23, 24]. Another patient with vaginal
ASPS had a recurrent 1.5-cm mass, 4 months after the
initial diagnosis [25].
The more favourable prognosis in ASPS located in the
uterine corpus may be due to small tumour size, ana-
tomical location or relative short duration of follow-up.
Indeed, in all patients, the ASPS of the uterine corpus,
except for the present case and the case reported by
Nolan and Gaffney, measured less than 5 cm [28]
(Table 2). Only in the case reported by Zhang et al. was
the pelvic and para-aortic lymph node metastasis observed
at diagnosis, but the duration of follow-up in this case was
short (9 months) and it is not possible to establish its
outcome [32].
Conclusions
An essential diagnostic marker in this unusual presenta-
tion of neoplasm is the nuclear over-expression of TFE3
as well as ultrastructural study, which reveals the pres-
ence of peculiar cytoplasmic crystalline inclusions.
Moreover, in our opinion, a larger number of cases of
ASPS in the female genital tract with longer follow-up
and pathological findings including sizes should help to
better define the biological nature of ASPS in the uterine
corpus. In addition, although lymph nodes metastasis was
observed only in the case of Zhang et al., surgical staging
with complete pelvic lymph nodes sampling could be use-
ful to evaluate therapy and prognosis of this rare
neoplasm.
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